The DOI matches its Crossref record; 252 of the 262 references it cites were found in a registry or an index.
The senescence-associated secretory phenotype and its physiological and pathological implications
Open accessAbstract
Cellular senescence is a state of terminal growth arrest associated with the upregulation of different cell cycle inhibitors, mainly p16 and p21, structural and metabolic alterations, chronic DNA damage responses, and a hypersecretory state known as the senescence-associated secretory phenotype (SASP). The SASP is the major mediator of the paracrine effects of senescent cells in their tissue microenvironment and of various local and systemic biological functions. In this Review, we discuss the composition, dynamics and heterogeneity of the SASP as well as the mechanisms underlying its induction and regulation. We describe the various biological properties of the SASP, its beneficial and detrimental effects in different physiological and pathological settings, and its impact on overall health span. Finally, we discuss the use of the SASP as a biomarker and of SASP inhibitors as senomorphic interventions to treat cancer and other age-related conditions.
Overview
CoChat Summary
TL;DR
This is a review of the senescence-associated secretory phenotype (SASP), summarizing its composition, regulation, and roles in physiology and disease. It also discusses SASP as a biomarker and SASP inhibitors as senomorphic therapies for cancer and other age-related conditions.
Key findings
- The paper states that cellular senescence is associated with terminal growth arrest, upregulation of cell cycle inhibitors mainly p16 and p21, structural and metabolic alterations, chronic DNA damage responses, and a hypersecretory state called the SASP.
- It identifies the SASP as the major mediator of the paracrine effects of senescent cells in their tissue microenvironment and of various local and systemic biological functions.
- The review covers the composition, dynamics, heterogeneity, induction, and regulation of the SASP, and its beneficial and detrimental effects in different physiological and pathological settings.
- It highlights the potential use of the SASP as a biomarker and of SASP inhibitors as senomorphic interventions to treat cancer and other age-related conditions.
Methods
- Design: Narrative review article.
- Data/sample: Not stated in the paper.
- Main analysis: The authors synthesize and discuss published knowledge on SASP biology, its mechanisms of induction/regulation, and its physiological and pathological implications.
Limitations
- The paper does not report original experimental data, sample size, or statistical analysis, because it is a review article (evident from the text).
- Specific limitations of the review itself are not stated in the paper.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 0 Not checked · 4 Own results and interpretations
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We describe the various biological properties of the SASP, its beneficial and detrimental effects in different physiological and pathological settings, and its impact on overall health span.”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We describe the various biological properties of the SASP, its beneficial and detrimental effects in different physiological and pathological settings, and its impact on overall health span.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Probably not a substantial claim. 2
- It may state two separate claims as one. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The progressive accumulation of senescent cells (SnCs) promotes chronic inflammation through the senescence-associated secretory phenotype (SASP)”
From Emerging strategies in senotherapeutics: from broad-spectrum senolysis to precision reprogramming (2026) · cites this paper as [10]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Zhang, B. et al. KDM4 orchestrates epigenomic remodeling of senescent cells and potentiates the senescence-associated secretory phenotype. Nat. Aging 1, 454–472 (2021).”
Cited work 10.1038/s43587-021-00063-1 · retracted 2024-10-31 · notice 10.1038/s43587-024-00749-2 · this paper published 2024-04-23
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
Cited work 10.1101/2020.08.03.235465 · retraction date not known · this paper published 2024-04-23
Citations
Cites
2 retracted
(2020) · doi:10.1101/2020.08.03.235465 · Cited by 66
Retracted(2021) · doi:10.1038/s43587-021-00063-1 · Cited by 66
RetractedThe limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 20×
“In addition, HMGA1 was upregulated in OIS and promoted the expression of nicotinamide phosphoribosyltransferase (NAMPT), which enhanced NAD + -mediated AMPK inhibition, thereby suppressing p53 and leading to the activation of a p38 MAPK-associated and NF-κB-associated pro-inflammatory proteins such as ATM and CHK2, AT…”
InfluentialVeldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605 · cited 2×
“Similar to senescent cells, T H 17 cells exert beneficial effects early during wound healing by promoting immune cell infiltration and induction of angiogenesis and neurogenesis 170 ; however, their chronic presence in tissues is associated with tissue fibrosis 172 .”
Cellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225 · cited 3×
“…senescence induced by loss of the phosphatase tumour suppressor PTEN , further deletion of TIMP1 , which encodes metalloproteinase inhibitor 1, reprogrammes the SASP to have a pro-tumorigenic function 106 , suggesting the existence of molecular switches that regulate different SASP modules…”
Self-citationNaturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
Type I interferons in infectious disease
McNab, F., Mayer-Barber, K., Sher, A., Wack, A., & O'Garra, A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3787 · Cited by 2,780
Rab27a and Rab27b control different steps of the exosome secretion pathway
Ostrowski, M., Carmo, N. B., Krumeich, S., Fanget, I., Raposo, G., Savina, A., Moita, C. F., Schauer, K., Hume, A. N., Freitas, R. P., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2000 · Cited by 2,750
Hallmarks of Cellular Senescence
Hernandez-Segura, A., Nehme, J., & Demaria, M. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.02.001 · Cited by 2,605
Self-citation
Research works printed but not linked: 2
- Loeser, R. F. The role of aging in the development of osteoarthritis. Trans. Am. Clin. Clim. Assoc. 128, 44–54 (2017).
- Wang, L., Chen, S. & Xu, K. IL-17 expression is correlated with hepatitis B-related liver diseases and fibrosis. Int. J. Mol. Med. 27, 385–392 (2010).
Cited by
From geroscience to precision geromedicine: Understanding and managing aging
Kroemer, G., Maier, A. B., Cuervo, A. M., Gladyshev, V. N., Ferrucci, L., Gorbunova, V., Kennedy, B. K., Rando, T. A., Seluanov, A., Sierra, F., et al. (2025) · Cell · doi:10.1016/j.cell.2025.03.011 · Cited by 395
Hallmarks of cancer—Then and now, and beyond
Hanahan, D. (2026) · Cell · doi:10.1016/j.cell.2025.12.049 · Cited by 225
Montégut, L., López-Otín, C., & Kroemer, G. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02020-z · Cited by 190
“This latter phenomenon, which is dubbed as senescence-associated secretory phenotype (SASP), explains the long-range effects of cellular senescence [73].”
BackgroundTargeting Senescence: A Review of Senolytics and Senomorphics in Anti-Aging Interventions
Saliev, T., & Singh, P. B. (2025) · Biomolecules · doi:10.3390/biom15060860 · Cited by 160
“The SASP is now recognized as a key mediator of the “inflammaging” process, a low-grade, chronic inflammation associated with aging, and has been implicated in a broad spectrum of diseases, including osteoarthritis, atherosclerosis, neurodegeneration, diabetes, and cancer [6,7].”
Glycolysis, the sweet appetite of the tumor microenvironment
Kooshan, Z., Cárdenas-Piedra, L., Clements, J. A., & Batra, J. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217156 · Cited by 141
Metadata
- Authors
- Wang, B., Han, J., Elisseeff, J. H., & Demaria, M.
- Affiliations
- University Medical Center Groningen (NL)
- Johns Hopkins University (US)
- Corresponding author
- Demaria, Marco
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2024-04-23
- Volume
- 25
- Issue
- 12
- Pages
- 958-978
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W4395050247
- Cited by
- 948
- References
- 262
- Citations by year
- 2026: 535 · 2025: 337 · 2024: 74
- FWCI
- 53.79
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- senescence-associated secretory phenotype, cellular senescence, paracrine signaling, senescent cells, p16, p21, DNA damage response, cancer therapy, age-related diseases, healthspan
- MeSH terms
- Senescence-Associated Secretory Phenotype, Aging, Animals, DNA Damage, Humans, Neoplasms, Phenotype, Biomarkers, Cellular Senescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The senescence-associated secretory phenotype and its physiological and pathological implications. https://app.cochat.ai/papers/10.1038/s41580-024-00727-x
- The paper
- Wang, B., Han, J., Elisseeff, J. H., & Demaria, M. (2024). The senescence-associated secretory phenotype and its physiological and pathological implications. Nature Reviews Molecular Cell Biology. https://doi.org/10.1038/s41580-024-00727-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.